Cullinan Therapeutics Inc.
CGEM | NASDAQ
$21.35
+$0.27 (+1.28%)
At close: Sep 21, 2026, 4:00 PM ET
$21.38
+$0.03 (+0.14%)
Pre-market:
Sep 22, 2026, 8:16 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -254.35M | -221.04M | -219.88M | -216.81M | -206.76M | -178.74M | -167.38M | -143.54M | -142.16M | -132.35M | -153.34M | -156.32M | -141.94M | 65.17M | 110.42M | 104.69M | 112.14M | -79.19M | -64.88M | -60.72M | -53.22M | -50.66M |
Depreciation & Amortization | 395K | 314K | 311K | 309K | 306K | 306K | 306K | 306K | 310K | 314K | 310K | 292K | 221K | 152K | 93K | 46K | 50K | 51K | 53K | 56K | 58K | 61K |
Stock-Based Compensation | 40.46M | 34.28M | 36.04M | 38.36M | 38.33M | 38.97M | 37.82M | 35.71M | 34.02M | 31.41M | 30.44M | 30.43M | 27.96M | 28.65M | 27.96M | 32.59M | 31.88M | 27.43M | 24.38M | 12.23M | 7.67M | 3.51M |
Other Working Capital | 9.67M | 13.47M | 14.92M | 13.16M | 8.15M | 4.03M | 423K | -3.06M | -2.99M | -9.1M | -172K | -8.1M | -42.79M | -32.9M | -34.82M | -24.05M | 10.97M | 3.75M | 1.29M | -3.34M | -2.74M | -1.23M |
Other Non-Cash Items | -4.4M | -4.77M | -6.31M | -8.89M | -12.46M | -14.47M | -15.66M | -11.25M | -9.53M | -7.95M | -5.82M | 35K | 8.6M | -202.98M | -200.66M | -195.84M | -196.62M | 17.98M | 17.26M | 20.09M | 14.97M | 20.76M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.13M | -5.52M | -5.52M | -5.52M | 607K | n/a | n/a | -19.57M | -19.57M | -19.57M | -19.57M | n/a | n/a | n/a | n/a |
Change in Working Capital | 12.6M | 12.58M | 14.08M | 12.76M | 9.06M | 3.72M | -389K | -1.9M | -3.92M | -7.42M | -339K | -8.66M | -43.39M | -33.97M | -32.12M | -21.36M | 15.77M | 6.17M | -3.54M | -4.8M | -5.7M | 58K |
Operating Cash Flow | -205.3M | -178.64M | -175.75M | -174.27M | -171.53M | -150.21M | -145.3M | -126.81M | -126.81M | -121.53M | -134.28M | -141.13M | -161.34M | -155.75M | -126.66M | -116.85M | -73.05M | -63.83M | -43.43M | -37.7M | -36.22M | -26.27M |
Capital Expenditures | -11K | -11K | -11K | n/a | n/a | n/a | n/a | n/a | n/a | -49K | -208K | -1.09M | -1.34M | -1.29M | -1.13M | -251K | n/a | n/a | n/a | 1K | -3K | -7K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 275.09M | 275.09M | 275.09M | 275.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -87.01M | -130.83M | -236.53M | -384.97M | -469.2M | -715.6M | -721.13M | -619.11M | -659.09M | -415.61M | -373.38M | -467.79M | -455.14M | -410.04M | -377.92M | -294.76M | -255.93M | -433.07M | -525.81M | -470.05M | -400.93M | -188.44M |
Sales Maturities Of Investments | 282.35M | 306.48M | 416.57M | 558.57M | 595.25M | 603.14M | 584.82M | 518.3M | 495.45M | 449.24M | 409.4M | 424.52M | 392.09M | 365.68M | 352.93M | 281.73M | 280.04M | 271.73M | 192.04M | 163.58M | 118.11M | 70.74M |
Other Investing Acitivies | -38K | -38K | -38K | -38K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -275M | -270M | 30.85M | 30.85M | 305.85M | 300.85M | n/a | n/a | n/a | n/a | 1.45M |
Investing Cash Flow | 195.29M | 175.6M | 179.99M | 173.56M | 126.05M | -112.47M | -136.31M | -100.81M | -163.64M | 33.58M | 35.81M | -44.27M | -59.29M | 229.45M | 248.98M | 261.72M | 294.11M | -161.34M | -333.78M | -306.47M | -282.82M | -116.26M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.83M | -375K | -375K | -1.18M | -2.2M | n/a | n/a | 800K | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | -656K | -4.45M | -4.45M | -4.45M | -3.97M | 36K | n/a | -33.28M | -33.1M | -33.32M | -30.54M | 2.74M | 2.74M | 3.66M | -1.77M | -1.77M | -1.77M | -2.69M |
Financial Cash Flow | 2.58M | 1.47M | 1.09M | 1.96M | 3.28M | 265.1M | 266.19M | 264.85M | 263.64M | 40.05M | 40.75M | 7.59M | 8.9M | -27.69M | -25.93M | 9.68M | 8.84M | 7.75M | 268.78M | 390.98M | 391.61M | 390.68M |
Net Cash Flow | -7.43M | -1.57M | 5.33M | 1.25M | -42.2M | 2.43M | -15.43M | 37.24M | -26.81M | -47.9M | -57.72M | -177.81M | -211.73M | 46.01M | 96.38M | 154.55M | 229.89M | -217.42M | -108.42M | 46.81M | 123.67M | 299.26M |
Free Cash Flow | -205.34M | -178.69M | -175.8M | -174.31M | -171.53M | -150.21M | -145.3M | -126.81M | -126.81M | -121.57M | -134.48M | -142.22M | -162.68M | -157.05M | -127.8M | -117.1M | -73.05M | -63.83M | -43.43M | -37.7M | -36.22M | -26.28M |
Adj. Free Cash Flow | -245.8M | -212.97M | -211.84M | -212.67M | -209.85M | -189.18M | -183.13M | -162.52M | -160.83M | -152.98M | -164.92M | -172.65M | -190.64M | -185.7M | -155.75M | -149.69M | -104.93M | -91.26M | -67.81M | -49.93M | -43.89M | -29.79M |
Maintenance CapEx | -11K | -11K | -11K | n/a | n/a | n/a | n/a | n/a | n/a | -49K | -208K | -1.09M | -1.34M | -1.29M | -1.13M | -251K | n/a | n/a | n/a | -1K | -5K | -9K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | 2K | 2K |
Owner Earnings | -205.31M | -178.65M | -175.76M | -174.27M | -171.53M | -150.21M | -145.3M | -126.81M | -126.81M | -121.57M | -134.48M | -142.22M | -162.68M | -157.05M | -127.8M | -117.1M | -73.05M | -63.83M | -43.43M | -37.7M | -36.22M | -26.28M |
Add to Watchlist
Select watchlists to add or remove CGEM